Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00089245
Status:
TERMINATED
Last Update Posted:
2023-12-26
First Post:
2004-08-04
Brief Title:
Radiolabeled MAB Therapy in Patients With Refractory Recurrent or Advanced CNS or Leptomeningeal Cancer
Sponsor:
Y-mAbs Therapeutics
Organization:
Y-mAbs Therapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Sarcoma |
| Brain and Central Nervous System Tumors |
| Neuroblastoma |
Keywords:
| Name | View |
|---|---|
| stage IV adult soft tissue sarcoma | View |
| leptomeningeal metastases | View |
| recurrent neuroblastoma | View |
| disseminated neuroblastoma | View |
| recurrent adult brain tumor | View |
| recurrent childhood medulloblastoma | View |
| recurrent childhood rhabdomyosarcoma | View |
| recurrent childhood soft tissue sarcoma | View |
| recurrent osteosarcoma | View |
| recurrent Ewing sarcomaperipheral primitive neuroectodermal tumor | View |
| childhood atypical teratoidrhabdoid tumor | View |
| adult medulloblastoma | View |
| previously treated childhood rhabdomyosarcoma | View |
| metastatic Ewing sarcomaperipheral primitive neuroectodermal tumor | View |
| metastatic osteosarcoma | View |
| childhood desmoplastic small round cell tumor | View |
| metastatic childhood soft tissue sarcoma | View |
| adult rhabdomyosarcoma | View |
| recurrent adult soft tissue sarcoma | View |